| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACVR1C
|
activin A receptor, type IC
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANGPT1
|
angiopoietin 1
|
|
APOE
|
apolipoprotein E
|
|
AR
|
androgen receptor
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BGN
|
biglycan
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTG2
|
BTG family, member 2
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCND1
|
cyclin D1
|
|
CCNG2
|
cyclin G2
|
|
CD33
|
CD33 molecule
|
|
CDC25C
|
cell division cycle 25C
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHKA
|
choline kinase alpha
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLDN4
|
claudin 4
|
|
CLU
|
clusterin
|
|
CNOT7
|
CCR4-NOT transcription complex, subunit 7
|
|
CNOT8
|
CCR4-NOT transcription complex, subunit 8
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYTH1
|
cytohesin 1
|
|
DCN
|
decorin
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLX4
|
distal-less homeobox 4
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
EPHB2
|
EPH receptor B2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV3
|
ets variant 3
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FHIT
|
fragile histidine triad
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FZD8
|
frizzled class receptor 8
|
|
GALNT2
|
polypeptide N-acetylgalactosaminyltransferase 2
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GH1
|
growth hormone 1
|
|
GHRH
|
growth hormone releasing hormone
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HEPACAM
|
hepatic and glial cell adhesion molecule
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HMOX1
|
heme oxygenase 1
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IL27
|
interleukin 27
|
|
IL6
|
interleukin 6
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF9
|
interferon regulatory factor 9
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LEP
|
leptin
|
|
LTF
|
lactotransferrin
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR106B
|
microRNA 106b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR133B
|
microRNA 133b
|
|
MIR17
|
microRNA 17
|
|
MIR208A
|
microRNA 208a
|
|
MIR20A
|
microRNA 20a
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR424
|
microRNA 424
|
|
MIR503
|
microRNA 503
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MST1
|
macrophage stimulating 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAP1L1
|
nucleosome assembly protein 1-like 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NES
|
nestin
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRG1
|
neuregulin 1
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OGDHL
|
oxoglutarate dehydrogenase-like
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP9
|
poly (ADP-ribose) polymerase family, member 9
|
|
PCDH17
|
protocadherin 17
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PGR
|
progesterone receptor
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RB1
|
retinoblastoma 1
|
|
RBM5
|
RNA binding motif protein 5
|
|
RFPL1
|
ret finger protein-like 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SEC14L2
|
SEC14-like 2 (S. cerevisiae)
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMOX
|
spermine oxidase
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TBX3
|
T-box 3
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFCP2
|
transcription factor CP2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TOB2
|
transducer of ERBB2, 2
|
|
TP53
|
tumor protein p53
|
|
TRIM21
|
tripartite motif containing 21
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSPYL2
|
TSPY-like 2
|
|
TXN
|
thioredoxin
|
|
UBQLN1
|
ubiquilin 1
|
|
UMPS
|
uridine monophosphate synthetase
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VIP
|
vasoactive intestinal peptide
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
ZFP36
|
ZFP36 ring finger protein
|
